Skip to main content
Top
Published in: International Journal of Hematology 1/2018

01-07-2018 | Images in Hematology

Dysplastic features seen in a patient with acute myeloid leukemia harboring the KTM2A-TET1 fusion gene

Published in: International Journal of Hematology | Issue 1/2018

Login to get access

Excerpt

Pancytopenia was noted in an apparently healthy 38-year-old woman at a regular medical checkup. Laboratory tests showed a hemoglobin level of 10.5 g/dL, 10.4 × 109/L platelets, and 1.1 × 109/L leukocytes, including 3.0% blasts. A bone marrow examination revealed 49.1% peroxidase-positive blasts with delicate nuclear chromatin and basophilic cytoplasm. Some of the blasts had Auer rods (Fig. 1 panels A, E). Flow cytometric analysis revealed positivity for CD13, CD33, CD117, HLA-DR, CD34 and CD38 among the blasts. Her bone marrow showed trilineage dysplasia, including pseudo-Pelger-Huët anomaly (Fig. 1 panels A, arrow, B, C) and hypogranular neutrophils, multi-nucleation (Fig. 1 panel D, arrow) and abnormal chromatin clumping in erythroblasts and many megakaryocytes with separated nuclei (Fig. 1 panels F–L, arrow). Paraffin sections of bone marrow aspirate showed the proliferation of dysplastic CD42b-expressing megakaryocytes (Fig. 1 panels M, N). Because dysplasia was observed in > 50% of the erythroid and megakaryocytic lineage cells, she was tentatively diagnosed with acute myeloid leukemia with myelodysplasia-related changes (AML-MRC). A chromosomal analysis indicated 46,XX,t(10;11)(q22;q23) [7]/46,XX [1]. Reverse transcription polymerase chain reaction and sequencing analyses revealed the KMT2A (MLL)-TET1 fusion gene with KMT2A exon 9 fused to TET1 exon 9 in frame. Her final diagnosis was AML with t(10;11)(q22;q23) ; KMT2A-TET1. …
Literature
1.
go back to reference Lee SG, Cho SY, Kim MJ, Oh SH, Cho EH, Lee S, et al. Genomic breakpoints and clinical features of MLL-TET1 rearrangement in acute leukemias. Haematologica. 2013;98:e55–7.CrossRef Lee SG, Cho SY, Kim MJ, Oh SH, Cho EH, Lee S, et al. Genomic breakpoints and clinical features of MLL-TET1 rearrangement in acute leukemias. Haematologica. 2013;98:e55–7.CrossRef
2.
Metadata
Title
Dysplastic features seen in a patient with acute myeloid leukemia harboring the KTM2A-TET1 fusion gene
Publication date
01-07-2018
Published in
International Journal of Hematology / Issue 1/2018
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-018-2469-4

Other articles of this Issue 1/2018

International Journal of Hematology 1/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine